Normal Distribution
nothing is called 95% until it has been counted
Concept

Stagewise ordering — where it appears

Ranking a sequential trial's possible outcomes by the look they stopped at, earlier being more extreme, and by the statistic within a look. Its p-values and intervals need no boundaries for looks after the stop, and it ranks every early crossing above any statistic at the last look.

Named by 3 essays across one field — each of them below, with the objects they name alongside it.

Ordered stagewise: the outcomes at least as extreme as stopping at 160 observations with z = 3.3. Each column is one look of an O'Brien–Fleming trial; above the boundary a trial stops there. Highlighted are the outcomes that count as at least as extreme as the observed one when outcomes are ordered stagewise: at 80, z ≥ 4.56 (probability 2.54 × 10⁻⁶ with no effect); at 160, z ≥ 3.30 (probability 4.82 × 10⁻⁴ with no effect); at 240, none; at 320, none; at 400, none. The two-sided p-value is 9.69 × 10⁻⁴.

The outcomes a trial could have stopped with

A trial that stops at its second look with z = 3.3 has a two-sided p-value of 0.000969, 0.000987, 0.00187 or 0.0421, depending on how the outcomes it could have stopped with are ordered. One of the four orderings does not change when the looks the trial never reached are replanned, and the same one gives a trial that ran to the end with z = 6 a p-value of 0.0256.

sequential · Stopping Forty trials at a true effect of 0.16, under the rule "power at the trend < 10%". The upper line is the benefit boundary (4.56, 3.23, 2.63, 2.28, 2.04); the lower line is where the rule stops a trial for futility (0.40 at 80, 0.66 at 160, 0.95 at 240, 1.31 at 320). Of forty trials with a real effect, 29 cross for benefit and 11 are stopped for futility.

A boundary for giving up

Adding "stop if z is below zero" to an O'Brien–Fleming trial costs 5.20 points of power at the effect it was designed for and halves the observations a trial with no effect uses. Stopping when conditional power at the observed trend falls under 10% costs 13.23 points and stops 21.28% of trials with a real effect. Making that rule binding lowers the benefit boundary from 2.040 to 1.901, and a binding rule that is then ignored rejects a true null 3.523% of the time instead of 2.5%.

sequential · Stopping The chance of crossing later from each interim z, under six schedules with O'Brien–Fleming-type spending boundaries. Exact. At an interim |z| of 1.0: end only 3.64%, +0.6 3.41%, +0.75 3.20%, +0.9 3.41%, every 0.125 3.00%, every 0.05 2.88%. At 2.5: end only 38.30%, +0.6 45.80%, +0.75 45.36%, +0.9 41.70%, every 0.125 50.08%, every 0.05 53.24%. The heavy line is the largest of the six at each z.

A look the trend asked for

Under an O'Brien–Fleming-type spending function, every schedule of looks fixed in advance spends exactly 5.0000%. A committee that adds a look at three quarters of the trial whenever the interim z is 1.5 or more spends 5.2323% — 5.315% counted over a hundred thousand trials — and the most a committee choosing among six schedules could spend is 5.4390%.

sequential · Stopping

Named alongside it

The objects these essays reach for when they reach for this one.

Closed formGroup-sequential designInterim analysisO'Brien–FlemingStopping ruleError rateMonte CarloStatistical powerAlpha spendingConditional distributionConditional powerConfidence interval

All concepts